By Rishika Sadam and Sriparna Roy HYDERABAD, Feb 17 (Reuters) - Indian drugmaker Dr Reddy’s Laboratories hopes to launch a ...
Generic drug manufacturers are facing increasing pressure from drug distributors, pharmacy benefit managers, and Indian competitors, leading to downward trends in generic drug prices. Which firms are ...
Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...
Shopping smart doesn’t mean sacrificing quality – sometimes the best deals hide in plain sight on store shelves. Generic products often deliver the same performance as their expensive counterparts, ...
The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to ...
This article was produced in partnership with The New York Times. Not all drug prices are going up. Amid the public fury over the escalating costs of brand-name medications, the prices of generic ...
Forbes contributors publish independent expert analyses and insights. I am a physician and behavioral scientist at Duke University. Brand-name chemotherapy is often incredibly expensive, in excess of ...
The value of the country’s generic medicine market is expected to reach over P400 billion by 2030, amid rising health care ...
The Food and Drug Administration approved the first direct generic competitor to the EpiPen on Thursday, setting the stage for cheaper competition that may lower prices. The new generic, which won’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results